Akebia Therapeutics, INC.
Biopharmaceutical company
Based in MA
🤖
AI Overview
With $1.4M in lobbying spend across 25 quarterly filings, Akebia Therapeutics, INC. is a significant lobbying presence.
$1.4M
Total Lobbying Spend
25
Quarterly Filings
1
Lobbying Firms Used
10
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2019 | $60K |
| 2020 | $240K |
| 2021 | $300K |
| 2022 | $240K |
| 2023 | $200K |
| 2024 | $200K |
| 2025 | $150K |
Lobbying Firms
BGR GOVERNMENT AFFAIRS
What They Lobby For
- Provide strategic guidance and counsel on issues impacting the biopharmaceutical industry.
- Provide strategic guidance and counsel on issues impacting the biopharmaceutical industry and HR 8177 - RAISE Act.
- Provide strategic guidance and counsel on issues impacting the biopharmaceutical industry and legislation to provide greater access to kidney care.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.